COMMUNIQUÉS West-GlobeNewswire

Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular Risk

14/11/2017 - 22:30

BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski

14/11/2017 - 22:15

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); and (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces that it has initiated a cancer research project to [...]

The Cooper Companies to Present at BMO Healthcare Conference

14/11/2017 - 22:15

PLEASANTON, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) will present at the BMO Prescriptions for Success Healthcare Conference in New York, NY, on December 14, 2017. Daniel G. [...]

Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer

14/11/2017 - 22:15

Company Also Added Key Members to the Senior Management Team Barbara Ruskin J.D. Ph.D. Appointed SVP, General Counsel and Chief Patent Officer Nenad Sarapa M.D. M.S. Appointed SVP of Clinical Development Conrad Jordaan [...]

Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director

14/11/2017 - 22:15

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced that on November 8, 2017, Precipio’s Board of Directors (the “Board”) appointed Samuel D. Riccitelli as Chairman, [...]

Asterias Biotherapeutics Reports Third Quarter Financial Results and Recent Developments

14/11/2017 - 22:10

- Continues to execute on key clinical programs and streamline cost structure - - Conference call and webcast today, November 14, at 4:30 p.m. ET - FREMONT, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Asterias [...]

HealthEquity Sets Date to Announce Third Quarter Results

14/11/2017 - 22:05

DRAPER, Utah, Nov. 14, 2017 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced that it plans to release its third quarter of [...]

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

14/11/2017 - 22:05

- Initiation of Phase 1 clinical trial of iMod.Fc on-track for this quarter - - Selection of antibody for ORCA program on-track for this quarter - SAN DIEGO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: [...]

Evoke Pharma Reports Third Quarter 2017 Results and Highlights

14/11/2017 - 22:05

Announced positive topline results from comparative exposure pharmacokinetic (PK) trial for Gimoti™ 505(b)(2) New Drug Application (NDA) submission on track for Q1 2018 filing Partnered with the Patheon division of [...]

Entellus Medical to Participate in Upcoming Investor Conferences

14/11/2017 - 22:05

PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL ), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the Company plans to [...]

Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference

14/11/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in [...]

Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update

14/11/2017 - 22:05

RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced [...]

Achillion Announces Proposed Secondary Offering of Common Stock

14/11/2017 - 22:03

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (“Achillion”) (NASDAQ: ACHN ) today announced that Johnson & Johnson Innovation-JJDC, Inc. (“JJDC”), an existing stockholder of [...]

Aptevo Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference

14/11/2017 - 22:02

SEATTLE, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]

Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results

14/11/2017 - 22:01

Completed Merger with Threshold Pharmaceuticals in August Recent Equity Financings of $60 Million Provide Cash Runway into late 2019 MT-3724 Advancing in Clinical Trials with New Data Expected in 1H18 AUSTIN, Texas, Nov [...]

Invuity to Present at Upcoming Investor Conferences

14/11/2017 - 22:01

SAN FRANCISCO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to attend the [...]

Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G

14/11/2017 - 22:01

- Greater than 50% improvement in proteinuria (albumin to creatinine ratio) after 14 days of oral dosing with ACH-4471 - - Improvement in complement alternative pathway biomarkers observed - NEW HAVEN, Conn., Nov. 14, [...]

Aptose Reports Results for the Third Quarter Ended September 30, 2017

14/11/2017 - 22:00

SAN DIEGO and TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that [...]

Southern Vein & Laser Center Announces Grand Opening of New Atlanta Location

14/11/2017 - 21:25

ATLANTA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Southern Vein & Laser Center is pleased to announce the grand opening of their new Atlanta office in Buckhead. On September 8, 2017, Dr. Richard Ambrozic held a public [...]